✦ LIBER ✦

A phase II trial of biochemical modulation using N- phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site

✍ Scribed by David Kelsen; Daniel S. Martin; Joseph Colofiore; Robert Sawyer; Daniel Coif

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 479 KB
Volume: 70
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19921001)70:7<1988::aid-cncr2820700730>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, II study of high-dose 5-fluor

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies

✍ Bach Ardalan; Kasi S. Sridhar; Pasquale Benedetto; Stephen Richman; Stuart Waldm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views

Phase I trial of low dose N-phosphonacet

Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas

✍ Bach Ardalan; Antonio Ucar; Rajender Reddy; Alan S. Livingstone; Arnold Markoe; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 1 views

A phase II multi-institutional trial of

A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

✍ Louise M. Morrell; Ardalan Bach; Stephen P. Richman; Phyllis Goodman; Thomas R. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 1 views

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer